IU Health Gastroenterology, Hepatology & Nutrition (Digestive & Liver Disorders) has a long tradition of excellence in patient care and innovation in research and education.
We have been consistently ranked among the top programs nationally by US News & World Report and have enormous breadth in our clinical and research expertise.
In partnership with the IU School of Medicine, IU Health physicians and researchers have the opportunity to stay on the forefront of new treatment advancements for patients with digestive and liver disorders. We are continuously investigating new ways to diagnose, treat, and prevent these conditions.
We have been consistently ranked among the top programs nationally by US News & World Report and have enormous breadth in our clinical and research expertise.
In partnership with the IU School of Medicine, IU Health physicians and researchers have the opportunity to stay on the forefront of new treatment advancements for patients with digestive and liver disorders. We are continuously investigating new ways to diagnose, treat, and prevent these conditions.
The IU Health Endoscopic Retrograde Cholangiopancreatography (ERCP) and Hepato-Pancreato-Biliary (HPB) surgery programs come together to be one of the most experienced, high volume programs in the country.
As one of the most experienced ERCP and Endoscopic Ultrasound (EUS) centers in the country, IU Health gastroenterologists have pioneered many of today’s standards for ERCP and EUS techniques and indications. Some of the advancements include device design, technique development, and milestone publications in peer-reviewed journals.
Dr. Easler is an Assistant Professor of Medicine at Indiana University School of Medicine with the Division of Gastroenterology and Hepatology and is the Director of the ERCP Fellowship Program.
The IU Health Liver Transplant Program offers a full spectrum of liver disease and transplant services for adults and children facing acute or chronic liver failure, primary liver malignancies, and metabolic or genetic disorders.
We are nationally recognized for our program’s excellent outcomes based on data released by the Scientific Registry of Transplant Recipients (SRTR) in August 2018. In addition, our program is ranked 3rd nationwide for liver transplant volume.
We also understand that organ access is a particularly important issue and we are addressing this challenge by incorporating new and revised protocols into our liver transplant program, to give even more patients access to this critical, lifesaving surgery. These protocols incorporate greater use of donation after circulatory death (DCD) livers while maintaining strong, positive outcomes
Dr. Kubal is the surgical director of the IU Health adult liver transplant program. His research interests include fatty liver disease, ischemic reperfusion injury in liver transplantation and liver regeneration.
Across the United States, over 14,000 patients are currently waiting for liver transplantation. Unfortunately, each year only 7,000 – 8,000 livers are donated. New organ allocation guidelines and underutilization of available organs has made access to organs even more challenging.
IU Health is finding organ access to be a particularly important issue. We are addressing this challenge by incorporating new and revised protocols into our liver transplant program. This gives even more patients access to this critical, lifesaving surgery. These protocols incorporate greater use of donation after circulatory death (DCD) livers while maintaining strong, positive outcomes.